Drugs / Certoparin
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01660295 | Dec 2011 → Jun 2012 | impaired renal function disease | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT01179620 | Nov 2010 → Mar 2011 | — | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT00451412 | Jan 2007 → Jun 2009 | venous thromboembolism | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT00311753 | Feb 2006 → Dec 2007 | venous thromboembolism | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00171769 | Apr 2005 → Aug 2006 | persistent atrial fibrillation | Novartis | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00196417 | Jan 2003 → Nov 2005 | heparin-induced thrombocytopenia | University Medicine Greifswald | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01164046 Comparator | Aug 2010 → Jul 2014 | neoplasm, venous thromboembolism | University Medical Center Groningen | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Certoparin | “certoparin” NCT01164046 ↗ |
| Modality | Other / unclassified | “low-molecular-weight heparin certoparin” NCT00171769 ↗ |
| Route | Subcutaneous | “Subcutaneously Injected Certoparin” NCT00171769 ↗ |